{"id":2532,"date":"2021-06-15T08:11:51","date_gmt":"2021-06-15T08:11:51","guid":{"rendered":"http:\/\/dexpatent.com\/insights\/?p=2532"},"modified":"2024-02-09T07:14:36","modified_gmt":"2024-02-09T07:14:36","slug":"axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19","status":"publish","type":"post","link":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/","title":{"rendered":"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2021\/06\/bio.png\" alt=\"AXIM\u00ae Biotechnologies files patent application for ELISA based diagnostic test for COVID-19\" width=\"679\" height=\"383\" class=\"aligncenter wp-image-2533 size-full\" title=\"AXIM\u00ae Biotechnologies files patent application for ELISA based diagnostic test for COVID-19\" \/><\/p>\n<h3><strong style=\"font-size: 19px;\">AXIM\u00ae Biotechnologies files patent application for ELISA based diagnostic test for COVID-19<\/strong><\/h3>\n<p>AXIM\u00ae Biotechnologies, Inc., an international healthcare solutions company announced the development and <strong><a href=\"https:\/\/www.dexpatent.com\/patent-filing\" title=\"Patent Filing\">patent filing<\/a><\/strong> for an enzyme-linked immunosorbent assay (ELISA)-based diagnostic test for the detection of SARS\u2010CoV-2 neutralizing antibodies. This application marks AXIM\u2019s fourth COVID-19 neutralizing antibody-focused patent application (<em>Source- globenewswire<\/em>)<\/p>\n<h3><strong style=\"font-size: 19px;\">Fermenta Biotech develops enzymatic synthesis of Molnupiravir \u2013 a COVID 19 therapeutic drug<\/strong><\/h3>\n<p>Fermenta Biotech Limited (FBL) <strong><a href=\"https:\/\/dexpatent.com\/patent-application-drafting\/\" title=\"Patent Application\">files a patent application<\/a><\/strong> for novel biocatalytic technology of manufacturing Molnupiravir. This patented enzymatic route of synthesis possesses the technological advantage of being efficient and environment-friendly, with higher yields and lower solvent use as compared to existing reported manufacturing processes. (<em>Source- theweek<\/em>)<\/p>\n<h3><strong style=\"font-size: 19px;\">Halberd Corporation files a PCT application for treating and curing Covid-19 infection utilizing a laser<\/strong><\/h3>\n<p>Halberd Corporation files an international Patent Cooperation Treaty (PCT) application for treating and curing Covid-19 infection by exposing the target antigens to laser energy.\u00a0 Halberd holds exclusive worldwide license to this technology. (<em>Source &#8211;\u00a0 finance.yahoo<\/em>)<\/p>\n<h3><strong style=\"font-size: 19px;\">AzurRx BioPharma and First Wave Bio files a patent application for niclosamide that treats COVID-19 GI diseases<\/strong><\/h3>\n<p>AzurRx BioPharma and\u00a0 First Wave Bio announces allowance of a patent application that covers use of niclosamide as a treatment for COVID-19-associated GI diseases.\u00a0 The claims of the patent application relate to a method for treating a digestive symptom in a subject diagnosed as having a COVID-19 viral infection by administering an effective amount of niclosamide to decrease viral RNA load relative to a baseline. (<em>Source-\u00a0 globenewswire<\/em>)<\/p>\n<h3><strong style=\"font-size: 19px;\">MGC Pharmaceuticals files a patent application for CimetrA that can treat COVID-19<\/strong><\/h3>\n<p>MGC\u00a0 Pharmaceuticals\u2019s patent application for CimetrA\u00a0 is designed to treat multiple ailments including COVID-19. The patent application is filed in Slovenian Intellectual Property Office (SIPO) and is expected to be issued within the next 12 months. (<em>Source- proactiveinvestors<\/em>)<\/p>\n<h3><strong style=\"font-size: 19px;\">Therapeutica Borealis receives a patent for coronavirus drug containing ivermectin and hydroxychloroquine<\/strong><\/h3>\n<p>Therapeutica Borealis, a Turku pharmaceutical company obtained a US patent for coronavirus drug. The nasal spray contains hydroxychloroquine among other ingredients. This drug will also help, especially in situations where vaccine coverage threatens to remain too low for livestock immunity, says Vaananen one of the three inventors and founders of Therapeutica Borealis. (<em>Source- nord.news<\/em>)<\/p>\n<h3><strong style=\"font-size: 19px;\">RedHill files patent applications for opaganib and RHB-107 in COVID-19<\/strong><\/h3>\n<p>RedHill Biopharma\u2019s patent applications covering opaganib and RHB-107 (upamostat) reveal methods for the treatment of COVID-19. The patent protection extends until at least 2041. (<em>Source- seekingalpha<\/em>)<\/p>\n<h3><strong style=\"font-size: 19px;\">Sunshine Biopharma files a non-provisional patent application for its COVID -19 treatment<\/strong><\/h3>\n<p>Sunshine Biopharma Inc. annonunces that it has filed a nonprovisional patent application in the form of a <strong><a href=\"https:\/\/www.dexpatent.com\/PCT-national-phase-india\/\">PCT<\/a><\/strong> in the United States for its COVID-19 treatment. In addition to the original subject matter disclosed in provisional patent application pertaining to inhibitors of the main coronavirus protease, Mpro, the PCT application contains data and extends coverage to include the papain-like coronavirus protease, PLpro. (<em>Source- globenewswire<\/em>)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AXIM\u00ae Biotechnologies files patent application for ELISA based diagnostic test for COVID-19 AXIM\u00ae Biotechnologies, Inc.,  <a class=\"moretag\" target=\"_blank\" href=\"insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/\" rel=\"noopener\">Read more<\/a\n<\/p>\n","protected":false},"author":2,"featured_media":5774,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","om_disable_all_campaigns":false,"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[48,109,110,126,211],"class_list":["post-2532","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patentnewzbox","tag-coronavirus","tag-ipinnovation","tag-ipnews","tag-patent","tag-trending-technology"],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test - Patent Insights | DexPatent<\/title>\n<meta name=\"description\" content=\"Fermenta Biotech Limited (FBL) files a patent application for novel biocatalytic technology of manufacturing Molnupiravir.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test - Patent Insights | DexPatent\" \/>\n<meta property=\"og:description\" content=\"Fermenta Biotech Limited (FBL) files a patent application for novel biocatalytic technology of manufacturing Molnupiravir.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Patent Insights | DexPatent\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-15T08:11:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-09T07:14:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2021\/06\/bio.png\" \/>\n\t<meta property=\"og:image:width\" content=\"675\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"DexPatent\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DexPatent\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/\"},\"author\":{\"name\":\"DexPatent\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#\\\/schema\\\/person\\\/cb9ad295f1f8542527d608ab5d9e8545\"},\"headline\":\"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test\",\"datePublished\":\"2021-06-15T08:11:51+00:00\",\"dateModified\":\"2024-02-09T07:14:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/\"},\"wordCount\":487,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/bio.png\",\"keywords\":[\"#coronavirus\",\"#ipinnovation\",\"#ipnews\",\"#patent\",\"#Trending technology\"],\"articleSection\":[\"Patent Newz Box\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/\",\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/\",\"name\":\"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test - Patent Insights | DexPatent\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/bio.png\",\"datePublished\":\"2021-06-15T08:11:51+00:00\",\"dateModified\":\"2024-02-09T07:14:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#\\\/schema\\\/person\\\/cb9ad295f1f8542527d608ab5d9e8545\"},\"description\":\"Fermenta Biotech Limited (FBL) files a patent application for novel biocatalytic technology of manufacturing Molnupiravir.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/bio.png\",\"contentUrl\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/bio.png\",\"width\":675,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2021\\\/06\\\/15\\\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/\",\"name\":\"Patent Insights | DexPatent\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#\\\/schema\\\/person\\\/cb9ad295f1f8542527d608ab5d9e8545\",\"name\":\"DexPatent\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"DexPatent\"},\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/author\\\/dexpatent\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test - Patent Insights | DexPatent","description":"Fermenta Biotech Limited (FBL) files a patent application for novel biocatalytic technology of manufacturing Molnupiravir.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/","og_locale":"en_US","og_type":"article","og_title":"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test - Patent Insights | DexPatent","og_description":"Fermenta Biotech Limited (FBL) files a patent application for novel biocatalytic technology of manufacturing Molnupiravir.","og_url":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/","og_site_name":"Patent Insights | DexPatent","article_published_time":"2021-06-15T08:11:51+00:00","article_modified_time":"2024-02-09T07:14:36+00:00","og_image":[{"width":675,"height":450,"url":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2021\/06\/bio.png","type":"image\/png"}],"author":"DexPatent","twitter_card":"summary_large_image","twitter_misc":{"Written by":"DexPatent","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#article","isPartOf":{"@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/"},"author":{"name":"DexPatent","@id":"https:\/\/dexpatent.com\/insights\/#\/schema\/person\/cb9ad295f1f8542527d608ab5d9e8545"},"headline":"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test","datePublished":"2021-06-15T08:11:51+00:00","dateModified":"2024-02-09T07:14:36+00:00","mainEntityOfPage":{"@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/"},"wordCount":487,"commentCount":0,"image":{"@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2021\/06\/bio.png","keywords":["#coronavirus","#ipinnovation","#ipnews","#patent","#Trending technology"],"articleSection":["Patent Newz Box"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/","url":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/","name":"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test - Patent Insights | DexPatent","isPartOf":{"@id":"https:\/\/dexpatent.com\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2021\/06\/bio.png","datePublished":"2021-06-15T08:11:51+00:00","dateModified":"2024-02-09T07:14:36+00:00","author":{"@id":"https:\/\/dexpatent.com\/insights\/#\/schema\/person\/cb9ad295f1f8542527d608ab5d9e8545"},"description":"Fermenta Biotech Limited (FBL) files a patent application for novel biocatalytic technology of manufacturing Molnupiravir.","breadcrumb":{"@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#primaryimage","url":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2021\/06\/bio.png","contentUrl":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2021\/06\/bio.png","width":675,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/dexpatent.com\/insights\/2021\/06\/15\/axim-biotechnologies-files-patent-application-elisa-based-diagnostic-test-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dexpatent.com\/insights\/"},{"@type":"ListItem","position":2,"name":"AXIM\u00ae Biotechnologies files patent for ELISA-based COVID-19 diagnostic test"}]},{"@type":"WebSite","@id":"https:\/\/dexpatent.com\/insights\/#website","url":"https:\/\/dexpatent.com\/insights\/","name":"Patent Insights | DexPatent","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dexpatent.com\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/dexpatent.com\/insights\/#\/schema\/person\/cb9ad295f1f8542527d608ab5d9e8545","name":"DexPatent","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"DexPatent"},"url":"https:\/\/dexpatent.com\/insights\/author\/dexpatent\/"}]}},"_links":{"self":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts\/2532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/comments?post=2532"}],"version-history":[{"count":5,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts\/2532\/revisions"}],"predecessor-version":[{"id":6101,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts\/2532\/revisions\/6101"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/media\/5774"}],"wp:attachment":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/media?parent=2532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/categories?post=2532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/tags?post=2532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}